Abstract
Monoamine oxidase (MAO) enzymes (MAO A and B) catalyze the oxidative deamination of biogenic amines, neurotransmitters, and xenobiotic amines and contribute to the regulation of the content of these active substances in mammalian organisms. The oxidation of biogenic amines by MAO produces hydrogen peroxide (H2O2) and aldehydes that represent risk factors for oxidative injury. The inhibitors of MAO are useful as antidepressants and neuroprotective agents. Usually, the assays of MAO determine amine deamination products or measure the H2O2 released by using direct spectrophotometric or fluorimetric methods. Direct methods are more prone to interferences and can afford inaccurate results. Those limitations can be avoided by using chromatographic techniques. This work describes a chromatographic method to assay MAO A and MAO B activity by using kynuramine as a nonselective substrate and the subsequent analysis of 4-hydroxyquinoline by RP-HPLC-DAD-fluorescence and mass spectrometry (MS). Alternatively, the assay uses the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin as a substrate of MAO that is oxidized (bioactivated) to neurotoxic pyridinium cations which are analyzed by HPLC. These methods are applied to assess the inhibition of MAO by bioactive β-carboline alkaloids occurring in foods, plants, and biological systems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Youdim MBH, Edmondson D, Tipton KF (2006) The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci 7:295–309
Shih JC, Chen K, Ridd MJ (1999) Monoamine oxidase: from genes to behavior. Annu Rev Neurosci 22:197–217
Edmondson DE, De Colibus L, Binda C, Li M, Mattevi A (2007) New insights into the structures and functions of human monoamine oxidases A and B. J Neural Transm 114:703–705
Edmondson DE, Mattevi A, Binda C, Li M, Hubálek F (2004) Structure and mechanism of monoamine oxidase. Curr Med Chem 11:1983–1993
Binda C, Mattevi A, Edmondson DE (2011) Structural properties of human monoamine oxidases A and B. Int Rev Neurobiol 100:1–11
Mallajosyula JK, Chinta SJ, Rajagopalan S, Nicholls DG, Andersen JK (2009) Metabolic control analysis in a cellular model of elevated MAO B: relevance to Parkinson’s disease. Neurotox Res 16:186–193
Mallajosyula JK, Kaur D, Chinta SJ, Rajagopalan S, Rane A, Nicholls DG, Di Monte DA, Macarthur H, Andersen JK (2008) MAO B elevation in mouse brain astrocytes results in Parkinson’s pathology. PLoS One 3:e1616
Bolasco A, Carradori S, Fioravanti R (2010) Focusing on new monoamine oxidase inhibitors. Expert Opin Ther Pat 20:909–939
Yamada M, Yasuhara H (2004) Clinical pharmacology of MAO inhibitors: safety and future. Neurotoxicology 25:215–221
Vindis C, Seguelas MH, Bianchi P, Parini A, Cambon C (2000) Monoamine oxidase B induces ERK-dependent cell mitogenesis by hydrogen peroxide generation. Biochem Bioph Res Co 271:181–185
Cohen G, Farooqui R, Kesler N (1997) Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow. Proc Natl Acad Sci USA 94:4890–4894
Hauptmann N, Grimsby J, Shih JC, Cadenas E (1996) The metabolism of tyramine by monoamine oxidase A/B causes oxidative damage to mitochondrial DNA. Arch Biochem Biophys 335:295–304
Bianchi P, Kunduzova O, Masini E, Cambon C, Bani D, Raimondi L, Seguelas MH, Nistri S, Colucci W, Leducq N, Parini A (2005) Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury. Circulation 112:3297–3305
Herraiz T, Guillén H (2018) Monoamine oxidase-A inhibition and associated antioxidant activity in plant extracts with potential antidepressant actions. Biomed Res Int 2018: 4810394
Youdim MBH, Weinstock M (2004) Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation. Neurotoxicology 25:243–250
Pisani L, Muncipinto G, Miscioscia TF, Nicolotti O, Leonetti F, Catto M, Caccia C, Salvati P, Soto-Otero R, Mendez-Alvarez E, Passeleu C, Carotti A (2009) Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7- (3-Chlorobenzyl)oxy -4- [(methylamino)methyl] -2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor. J Med Chem 52:6685–6706
Herraiz T, Arán VJ, Guillén H (2009) Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO). Free Radic Res 43:975–984
Herraiz T, Brandt SD (2014) 5-(2-Aminopropyl)indole (5-IT): a psychoactive substance used for recreational purposes is an inhibitor of human monoamine oxidase (MAO). Drug Test Anal 6:607–613
Chimenti F, Cottiglia F, Bonsignore L, Casu L, Casu M, Floris C, Secci D, Bolasco A, Chimenti P, Granese A, Befani O, Turini P, Alcaro S, Ortuso F, Trombetta G, Loizzo A, Guarino I (2006) Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO A: extraction, biological analysis, and computational study. J Nat Prod 69:945–949
Dreiseitel A, Korte G, Schreier P, Oehme A, Locher S, Domani M, Hajak G, Sand PG (2009) Berry anthocyanins and their aglycons inhibit monoamine oxidases A and B. Pharmacol Res 59:306–311
Novaroli L, Daina A, Favre E, Bravo J, Carotti A, Leonetti F, Catto M, Carrupt PA, Reist M (2006) Impact of species-dependent differences on screening, design, and development of MAO B inhibitors. J Med Chem 49:6264–6272
Albers AE, Rawls KA, Chang CJ (2007) Activity-based fluorescent reporters for monoamine oxidases in living cells. Chem Commun 2007: 4647–4649
Chaurasiya ND, Ibrahim MA, Muhammad I, Walker LA, Tekwani BL (2014) Monoamine oxidase inhibitory constituents of propolis: kinetics and mechanism of inhibition of recombinant human MAO A and MAO B. Molecules 19:18936–18952
Klein-Júnior LC, Viaene J, Tuenter E, Salton J, Gasper AL, Apers S, Andries JPM, Pieters L, Henriques AT, van der Heyden Y (2016) The use of chemometrics to study multifunctional indole alkaloids from Psychotria nemorosa (Palicourea comb. nov.). Part II: indication of peaks related to the inhibition of butyrylcholinesterase and monoamine oxidase-A. J Chromatogr A 1463:71–80
Strydom B, Malan SF, Castagnoli N, Bergh JJ, Petzer JP (2010) Inhibition of monoamine oxidase by 8-benzyloxycaffeine analogues. Bioorg Med Chem 18:1018–1028
van Diermen D, Marston A, Bravo J, Reist M, Carrupt PA, Hostettmann K (2009) Monoamine oxidase inhibition by Rhodiola rosea L. roots. J Ethnopharmacol 122:397–401
Xu Y, Wang Z, You W, Zhang X, Li S, Barish PA, Vernon MM, Du X, Li GW, Pan J, Ogle WO (2010) Antidepressant-like effect of trans-resveratrol: involvement of serotonin and noradrenaline system. Eur Neuropsychopharmacol 20:405–413
Zarmouh NO, Messeha SS, Mateeva N, Gangapuram M, Flowers K, Eyunni SVK, Zhang W, Redda KK, Soliman KFA (2020) The antiproliferative effects of flavonoid MAO inhibitors on prostate cancer cells. Molecules 25:2257
Zhou M, Panchuk Voloshina N (1997) A one-step fluorometric method for the continuous measurement of monoamine oxidase activity. Anal Biochem 253:169–174
Holt A, Sharman DF, Baker GB, Palcic MM (1997) A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates. Anal Biochem 244:384–392
Kumar MJ, Nicholls DG, Andersen JK (2003) Oxidative alpha-ketoglutarate dehydrogenase inhibition via subtle elevations in monoamine oxidase B levels results in loss of spare respiratory capacity. Implications for Parkinson's disease. J Biol Chem 278:46432–46439
Guang HM, Du GH (2006) High-throughput screening for monoamine oxidase-A and monoamine oxidase-B inhibitors using one-step fluorescence assay. Acta Pharmacol Sin 27:760–766
Trouche E, Mias C, Seguelas MH, Ordener C, Cussac D, Parini A (2010) Characterization of monoamine oxidases in mesenchymal stem cells: role in hydrogen peroxide generation and serotonin-dependent apoptosis. Stem Cells Dev 19:1571–1578
Herraiz T, Chaparro C (2005) Human monoamine oxidase is inhibited by tobacco smoke: ß-carboline alkaloids act as potent and reversible inhibitors. Biochem Biophys Res Co 326:378–386
Herraiz T, Chaparro C (2006) Analysis of monoamine oxidase enzymatic activity by reversed-phase high performance liquid chromatography and inhibition by ß-carboline alkaloids occurring in foods and plants. J Chromatogr A 1120:237–243
Herraiz T, Chaparro C (2006) Human monoamine oxidase enzyme inhibition by coffee and ß-carbolines norharman and harman isolated from coffee. Life Sci 78:795–802
Yan ZY, Caldwell GW, Zhao BY, Reitz AB (2004) A high-throughput monoamine oxidase inhibition assay using liquid chromatography with tandem mass spectrometry. Rapid Commun Mass Spectrom 18:834–840
Wagmann L, Brandt SD, Kavanagh PV, Maurer HH, Meyer MR (2017) In vitro monoamine oxidase inhibition potential of alpha-methyltryptamine analog new psychoactive substances for assessing possible toxic risks. Toxicol Lett 272:84–93
Herraiz T (2012) Evaluation of the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to toxic pyridinium cations by monoamine oxidase (MAO) enzymes and its use to search for new MAO inhibitors and protective agents. J Enzyme Inhib Med Chem 27:810–817
Herraiz T, Guillén H, Galisteo J (2013) Metabolite profile resulting from the activation/inactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 2-methyltetrahydro-ß-carboline by oxidative enzymes. Biomed Res Int 2013: 248608
Kalgutkar AS, Dalvie DK, Castagnoli N, Taylor TJ (2001) Interactions of nitrogen-containing xenobiotics with monoamine oxidase (MAO) isozymes A and B: SAR studies on MAO substrates and inhibitors. Chem Res Toxicol 14:1139–1162
Herraiz T, Guillén H, Arán VJ, Idle JR, Gonzalez FJ (2006) Comparative aromatic hydroxylation and N-demethylation of MPTP neurotoxin and its analogs, N-methylated β-carboline and isoquinoline alkaloids, by human cytochrome P450 2D6. Toxicol Appl Pharmacol 216:387–398
Jiang B, Li S, Liu W, Yang Y, Chen W, He D, Cheng X, Wang Z, Chen W, Wang C (2015) Inhibitive activities detection of monoamine oxidases (MAO) A and B inhibitors in human liver MAO incubations by UPLC–ESI-MS/MS. J Pharmaceut Biomed Anal 115:283–291
Herraiz T, Flores A, Fernandez L (2018) Analysis of monoamine oxidase (MAO) enzymatic activity by high-performance liquid chromatography-diode array detection combined with an assay of oxidation with a peroxidase and its application to MAO inhibitors from foods and plants. J Chromatogr B: Anal Technol Biomed Life Sci 1073:136–144
Herraiz T, Guillen H (2011) Inhibition of the bioactivation of the neurotoxin MPTP by antioxidants, redox agents and monoamine oxidase inhibitors. Food Chem Toxicol 49:1773–1781
Kim H, Sablin SO, Ramsay RR (1997) Inhibition of monoamine oxidase A by beta-carboline derivatives. Arch Biochem Biophys 337:137–142
Herraiz T, Gonzalez D, Ancin-Azpilicueta C, Aran VJ, Guillen H (2010) ß-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO). Food Chem Toxicol 48:839–845
Herraiz T (2007) Identification and occurrence of ß-carboline alkaloids in raisins and inhibition of monoamine oxidase (MAO). J Agric Food Chem 55:8534–8540
Herraiz T (1998) Occurrence of 1,2,3,4-tetrahydro-ß-carboline-3-carboxylic acid and 1-methyl-1,2,3,4-tetrahydro-ß-carboline-3-carboxylic acid in fruit juices, purees, and jams. J Agric Food Chem 46:3484–3490
Carpéne C, Hasnaoui M, Balogh B, Matyus P, Fernández-Quintela A, Rodríguez V, Mercader J, Portillo MP (2016) Dietary phenolic compounds interfere with the fate of hydrogen peroxide in human adipose tissue but do not directly inhibit primary amine oxidase activity. Oxidat Med Cell Long 2016:2427618
Herraiz T (2016) N-methyltetrahydropyridines and pyridinium cations as toxins and comparison with naturally-occurring alkaloids. Food Chem Toxicol 97:23–39
Acknowledgements
The author thank the Spanish Government-FEDER through projects RTI2018-093940-B-I00 and RTI2018-095544-B-I00.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Herraiz, T. (2023). Assay of MAO Inhibition by Chromatographic Techniques (HPLC/HPLC-MS). In: Binda, C. (eds) Monoamine Oxidase. Methods in Molecular Biology, vol 2558. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2643-6_8
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2643-6_8
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2642-9
Online ISBN: 978-1-0716-2643-6
eBook Packages: Springer Protocols